{"nctId":"NCT00997594","briefTitle":"Changes in Adrenal Hormones During Adrenal Radiofrequency Ablation","startDateStruct":{"date":"2009-10"},"conditions":["Adrenal Tumors"],"count":18,"armGroups":[{"label":"Adrenal radiofrquency (RF) ablation","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: Radiofrequency ablation"]},{"label":"Abdominal RF ablation other than adrenal gland","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: Radiofrequency ablation"]}],"interventions":[{"name":"Radiofrequency ablation","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Unresectable adrenal tumor which will be treated by radiofrequency (RF)ablation\n* Blood pressure is 140mmHg or less before RF ablation\n* Age of 20-years or more\n* Performance status of 0 or 1\n* Agreement from the patient\n\nExclusion Criteria:\n\n* Platelet count of 50,000/mm\\^3 or International normalized ratio (INR)\\>1.5","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Increase in Catecholamine","description":null,"classes":[]},{"type":"SECONDARY","title":"Increase in Cortisol","description":null,"classes":[]},{"type":"PRIMARY","title":"Serum Cathecholamine Levels","description":null,"classes":[]},{"type":"PRIMARY","title":"Number of Participants With Hypertension During Adrenal or Non-adrenal Radiofrequency Ablation","description":"Blood pressure was monitored during radiofrequency (RF) ablation. The frequency of hypertension (systolic blood pressure of more than 200 mmHg) was evaluated and compared between the adrenal and non-adrenal (RF ablation other than adrenal gland) RF ablation groups.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":9},"commonTop":[]}}}